Revium Rx reported total assets of $7.11M and total liabilities of $1.59M for the quarter ended Jun 2026. This balance sheet covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & EquivalentsCash & Equiv. | 3.27M | 1.68M | 0.84M | |
| Short-term InvestmentsInvestments (Current) | 2.01M | 1.03M | 0.66M | |
| Cash & Current Investments | 5.28M | 2.71M | 1.51M | |
| Prepaid Assets | 0.24M | 0.38M | 0.34M | |
| Current Assets | 5.52M | 3.10M | 1.86M | |
| Non-Current Assets | ||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.01M | 0.01M | 0.01M | |
| Goodwill | 11.41M | 2.58M | 2.58M | |
| Intangibles | 3.34M | 2.50M | 2.50M | |
| Goodwill & Intangibles | 14.76M | 5.07M | 5.07M | |
| Long-Term Deferred Tax | 5.54M | 9.22M | ||
| Non-Current Assets | 14.77M | 5.21M | 5.25M | |
| Assets | 20.28M | 8.30M | 7.11M | |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payables | 0.14M | 0.16M | 0.62M | |
| Notes Payables | 0.22M | 0.00M | 0.00M | |
| Payables | 0.36M | 0.16M | 0.62M | |
| Current Leases | 0.06M | 0.08M | ||
| Total Current Liabilities | 0.58M | 0.80M | 0.97M | |
| Non-Current Liabilities | ||||
| Minority Interest | 0.77M | |||
| Operating Leases | 0.05M | 0.04M | ||
| Other Non-Current Liabilities | 0.57M | 0.57M | ||
| Total Non-Current Liabilities | 0.62M | 0.62M | ||
| Total Liabilities | 0.58M | -18.53M | 1.42M | 1.59M |
| Shareholder's Equity | ||||
| Total Debt | 0.22M | 0.00M | 0.00M | |
| Common Equity | 19.71M | 18.53M | 6.88M | 5.52M |
| Liabilities and Shareholders Equity | 20.28M | 8.30M | 7.11M | |
| Retained Earnings | 30.39M | 31.78M | 31.89M |